ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.040
+0.250 (13.97%)
At close: Jun 26, 2026, 4:00 PM EDT
2.002
-0.038 (-1.84%)
After-hours: Jun 26, 2026, 7:30 PM EDT
ALX Oncology Holdings Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for ALX Oncology Holdings stock have an average target of 4.75, with a low estimate of 4.00 and a high estimate of 6.00. The average target predicts an increase of 132.84% from the current stock price of 2.04.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 12, 2026.
Analyst Ratings
The average analyst rating for ALX Oncology Holdings stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 17, 2026 |
| UBS | UBS | Buy Maintains $6 | Buy | Maintains | $6 | +194.12% | May 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $4 | Buy | Maintains | $4 | +96.08% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $4 | Buy | Reiterates | $4 | +96.08% | May 11, 2026 |
| Wells Fargo | Wells Fargo | Buy Initiates $5 | Buy | Initiates | $5 | +145.10% | Mar 19, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.65
from -1.66
EPS Next Year
-0.54
from -0.65
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.65 | -0.54 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.